SynthesisHuman vaccines & immunotherapeutics2024

Risk and safety profile in checkpoint inhibitors on non-small-cel lung cancer: A systematic review.

Sara Maria MajernikovaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.